Kerry Group acquires majority of the shares of c-LEcta GmbH. The previous management of c-LEcta remains on board. Acquisition promotes c-LEcta's growth potential and allows access to new markets
Leipzig-based biotech company continues on its growth course of past years in 2021 and expects revenue in the range of EUR 20 million Revenue was thus approximately doubled compared to the